Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Change in Acquisitions & Divestments: 2019-2025

Historic Change in Acquisitions & Divestments for Phibro Animal Health (PAHC) over the last 3 years, with Sep 2025 value amounting to $9.0 million.

  • Phibro Animal Health's Change in Acquisitions & Divestments rose 50.00% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.0 million, marking a year-over-year decrease of 0.89%. This contributed to the annual value of $49.0 million for FY2025, which is 20.35% down from last year.
  • Per Phibro Animal Health's latest filing, its Change in Acquisitions & Divestments stood at $9.0 million for Q3 2025, which was up 80.00% from $5.0 million recorded in Q2 2025.
  • Phibro Animal Health's Change in Acquisitions & Divestments' 5-year high stood at $38.0 million during Q4 2024, with a 5-year trough of $4.5 million in Q2 2024.
  • Its 3-year average for Change in Acquisitions & Divestments is $14.9 million, with a median of $9.0 million in 2025.
  • As far as peak fluctuations go, Phibro Animal Health's Change in Acquisitions & Divestments crashed by 63.16% in 2022, and later soared by 210.00% in 2023.
  • Quarterly analysis of 5 years shows Phibro Animal Health's Change in Acquisitions & Divestments stood at $24.0 million in 2021, then tumbled by 58.33% to $10.0 million in 2022, then soared by 210.00% to $31.0 million in 2023, then increased by 22.58% to $38.0 million in 2024, then skyrocketed by 50.00% to $9.0 million in 2025.
  • Its last three reported values are $9.0 million in Q3 2025, $5.0 million for Q2 2025, and $38.0 million during Q4 2024.